Mpox vaccination shortage delays Kinshasa’s campaign, Congo organiser says
The World Health Organisation declared mpox a global health emergency in mid-August, after a new strain began spreading from ...
GlobalData on MSN6d
Bavarian Nordic’s mpox vaccine to be trialled in pregnant women and infants
Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.
Daily Sabah8h
DRC struggles to vaccinate against mpox as cases skyrocket
A spokesperson for Bavarian Nordic said 265,000 doses of its mpox vaccine, Jynneos, had been delivered to African countries, ...
FiercePharma27d
NIH study shows Bavarian Nordic's mpox shot elicits immune response in teens
While Bavarian Nordic’s vaccine Jynneos is approved in several countries to prevent mpox and smallpox infections in adults, there has been a lack of data to support its approval in adolescents.
pharmaphorum3d
NIH study backs Bavarian Nordic mpox jab for adolescents
An independent study has found that Bavarian Nordic's mpox vaccine Jynneos – currently only authorised for use in adults in the US – is also safe and generates a strong antibody response in ...
WHO approves Bavarian Nordic's mpox vaccine for adolescents
The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the ...
Yahoo Finance28d
Bavarian Nordic’s mpox vaccine equally effective in teens as adults
A clinical trial by the US National Institutes of Health (NIH) has shown that Bavarian Nordic’s mpox vaccine induced an antibody response in adolescents equivalent to that of adults. The interim ...
Vaccine Doses Allocated for 9 African Countries Hardest Hit by Mpox
(Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the ...
Mpox vaccine doses divvied up for 9 African countries
An initial 899,000 vaccine doses have been allocated for nine countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organizations say.
Finanznachrichten15d
Bavarian Nordic A/S: First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic's Mpox Vaccine
COPENHAGEN, Denmark, October 29, 2024 - Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a clinical study of the MVA-BN ® mpox/smallpox vaccine in children 2 to 11 years of age.
The Straits Times1mon
WHO approves Bavarian Nordic's mpox vaccine for adolescents
The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the ...
MyJoyOnline1mon
WHO approves Bavarian Nordic’s mpox vaccine for adolescents
The World Health Organisation said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the ...